ABCAM PLC-SPON ADR (ABCM) Fundamental Analysis & Valuation

NASDAQ:ABCM • US0003802040

23.99 USD
+0.01 (+0.04%)
At close: Dec 5, 2023
23.99 USD
0 (0%)
After Hours: 12/5/2023, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ABCM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ABCM. ABCM was compared to 519 industry peers in the Biotechnology industry. Both the profitability and the financial health of ABCM get a neutral evaluation. Nothing too spectacular is happening here. ABCM is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. ABCM Profitability Analysis

1.1 Basic Checks

  • ABCM had positive earnings in the past year.
  • ABCM had a positive operating cash flow in the past year.
ABCM Yearly Net Income VS EBIT VS OCF VS FCFABCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

  • The Return On Assets of ABCM (0.64%) is better than 93.86% of its industry peers.
  • With an excellent Return On Equity value of 0.93%, ABCM belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
  • ABCM has a Return On Invested Capital of 1.98%. This is amongst the best in the industry. ABCM outperforms 94.69% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ABCM is significantly below the industry average of 19.44%.
  • The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROIC 1.98%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ABCM Yearly ROA, ROE, ROICABCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.94%, ABCM belongs to the top of the industry, outperforming 94.86% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ABCM has declined.
  • ABCM's Operating Margin of 8.70% is amongst the best of the industry. ABCM outperforms 95.36% of its industry peers.
  • ABCM's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 72.69%, ABCM belongs to the best of the industry, outperforming 83.58% of the companies in the same industry.
  • ABCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
ABCM Yearly Profit, Operating, Gross MarginsABCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ABCM Health Analysis

2.1 Basic Checks

  • ABCM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ABCM has more shares outstanding
  • Compared to 1 year ago, ABCM has an improved debt to assets ratio.
ABCM Yearly Shares OutstandingABCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
ABCM Yearly Total Debt VS Total AssetsABCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 8.64 indicates that ABCM is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 8.64, ABCM belongs to the top of the industry, outperforming 85.41% of the companies in the same industry.
  • The Debt to FCF ratio of ABCM is 19.99, which is on the high side as it means it would take ABCM, 19.99 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 19.99, ABCM belongs to the top of the industry, outperforming 94.03% of the companies in the same industry.
  • A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
  • ABCM has a worse Debt to Equity ratio (0.30) than 71.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Altman-Z 8.64
ROIC/WACC0.22
WACC8.89%
ABCM Yearly LT Debt VS Equity VS FCFABCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.3 Liquidity

  • ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ABCM (1.26) is worse than 86.73% of its industry peers.
  • A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
  • ABCM has a Quick ratio of 0.98. This is amonst the worse of the industry: ABCM underperforms 88.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.98
ABCM Yearly Current Assets VS Current LiabilitesABCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ABCM Growth Analysis

3.1 Past

  • ABCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 402.64%, which is quite impressive.
  • Measured over the past years, ABCM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.30% on average per year.
  • ABCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.70%.
  • Measured over the past years, ABCM shows a quite strong growth in Revenue. The Revenue has been growing by 11.64% on average per year.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%

3.2 Future

  • ABCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.12% yearly.
  • The Revenue is expected to grow by 11.28% on average over the next years. This is quite good.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ABCM Yearly Revenue VS EstimatesABCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
ABCM Yearly EPS VS EstimatesABCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

6

4. ABCM Valuation Analysis

4.1 Price/Earnings Ratio

  • ABCM is valuated quite expensively with a Price/Earnings ratio of 44.43.
  • Compared to the rest of the industry, the Price/Earnings ratio of ABCM indicates a rather cheap valuation: ABCM is cheaper than 94.69% of the companies listed in the same industry.
  • ABCM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.70.
  • Based on the Price/Forward Earnings ratio of 49.32, the valuation of ABCM can be described as expensive.
  • 94.53% of the companies in the same industry are more expensive than ABCM, based on the Price/Forward Earnings ratio.
  • ABCM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
ABCM Price Earnings VS Forward Price EarningsABCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 94.20% of the companies in the same industry are more expensive than ABCM, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ABCM is valued cheaper than 93.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 374.67
EV/EBITDA 55.61
ABCM Per share dataABCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ABCM may justify a higher PE ratio.
  • ABCM's earnings are expected to grow with 52.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ABCM Dividend Analysis

5.1 Amount

  • ABCM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ABCM Fundamentals: All Metrics, Ratios and Statistics

ABCAM PLC-SPON ADR

NASDAQ:ABCM (12/5/2023, 8:00:00 PM)

After market: 23.99 0 (0%)

23.99

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-12
Earnings (Next)N/A
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 44.43
Fwd PE 49.32
P/S 12.3
P/FCF 374.67
P/OCF 79.64
P/B 5.92
P/tB 42.37
EV/EBITDA 55.61
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.93%
ROCE 3.54%
ROIC 1.98%
ROICexc 2.23%
ROICexgc 7.95%
OM 8.7%
PM (TTM) 1.94%
GM 72.69%
FCFM 3.28%
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 19.99
Debt/EBITDA 2.79
Cap/Depr 90.64%
Cap/Sales 12.16%
Interest Coverage 9.53
Cash Conversion 69.81%
Profit Quality 169.12%
Current Ratio 1.26
Quick Ratio 0.98
Altman-Z 8.64
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%

ABCAM PLC-SPON ADR / ABCM FAQ

Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?

ChartMill assigns a fundamental rating of 6 / 10 to ABCM.


Can you provide the valuation status for ABCAM PLC-SPON ADR?

ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.


What is the profitability of ABCM stock?

ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.


What is the valuation of ABCAM PLC-SPON ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ABCAM PLC-SPON ADR (ABCM) is 44.43 and the Price/Book (PB) ratio is 5.92.


What is the earnings growth outlook for ABCAM PLC-SPON ADR?

The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.